Table 3: NLH and MMC COVID-19 patient registries inpatient therapies.
|
Therapy, n (%) |
NLH |
MaineMed |
Total |
|
Antibiotics |
45 (75) |
139 (61) |
184 (64) |
|
Systemic steroids |
22 (37) |
8 (4) |
30 (10) |
|
NSAIDs |
7 (12) |
11 (5) |
18 (6) |
|
ACE/ARB inpatient |
11 (18) |
3 (1) |
14 (5) |
|
Hydroxychloroquine |
8 (13) |
50 (22) |
58 (20) |
|
Convalescent plasma |
8 (13) |
9 (4) |
17 (6) |
|
Tocilizumab |
1 (2) |
14 (6) |
15 (5) |
|
Remdesivir |
22 (37) |
12 (5) |
34 (12) |
Note: NLH: Northern Light Health; MMC: Maine Medical Center; NSAIDs: Non-Steroidal Anti-Inflammatory Drugs; ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin Receptor Blocker